Archive ready

一般財団法人化学及血清療法研究所が製造販売する組換え沈降B型肝炎ワクチン(酵母由来)、乾燥組織培養不活化A型肝炎ワクチンについて|厚生労働省

https://www.mhlw.go.jp/stf/houdou/0000110599.html
April 4, 2026 at 09:30 AM JSTThe archive page, viewer, and downloads use this saved version.
April 4, 2026 at 09:30 AM JST·www.mhlw.go.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved page

一般財団法人化学及血清療法研究所が製造販売する組換え沈降B型肝炎ワクチン(酵母由来)、乾燥組織培養不活化A型肝炎ワクチンについて|厚生労働省

Open the archived HTML with saved-time metadata attached.

StartedApril 4, 2026 at 09:30 AM JST

This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.

About this pageAI generated

This page announces the Ministry of Health, Labour and Welfare's decision to lift the shipment suspension of hepatitis B vaccine "Beamgen" and hepatitis A vaccine "Eimgen" manufactured by the Chemical and Serum Therapy Research Institute. The suspension was issued in September 2015 due to discrepancies between approved specifications and actual manufacturing practices. After detailed review, authorities determined no significant impact on quality and safety. Based on the Infectious Disease Subcommittee's recommendation and supply shortage concerns, shipment approval was restored.

一般財団法人化学及血清療法研究所が製造販売する組換え沈降B型肝炎ワクチン(酵母由来)、乾燥組織培養不活化A型肝炎ワクチンについて|厚生労働省 - Saved screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.